Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma
2 clinical trials · Condition
◉ Watch Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| Durvalumab With or Without Lenalidomide in Treating Patients With Relapsed or Refractory Cutaneous or Peripheral T Cell Lymphoma (NCT03011814) | City of Hope Medical Center | 2017-03-08 |
Track Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.